Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

Autor: Frishberg, Yaacov, Deschênes, Georges, Groothoff, Jaap W., Hulton, Sally-Anne, Magen, Daniella, Harambat, Jérôme, van’t Hoff, William G., Lorch, Ulrike, Milliner, Dawn S., Lieske, John C., Haslett, Patrick, Garg, Pushkal P., Vaishnaw, Akshay K., Talamudupula, Sandeep, Lu, Jiandong, Habtemariam, Bahru A., Erbe, David V., McGregor, Tracy L., Cochat, Pierre, Bandara, Asela, Bowen, Jonathan, Chong, Wei Li, Coates, Simon, De Barr, Patrick, De Beer, Janine, Gayed, Juleen, Hill, Timothy, Kotak, Alex, Ono, Junko, Taubel, Jorg, Thayalan, Meera, Wong, Robynne, Coch, Christoph, Coenen, Martin, Feldkotter, Markus, Heiland, Nils Henning, Hohenadel, Maximilian, Hoppe, Bernd, Kyrieleis, Henriette, Schalk, Gesa, Cooper, Lucy, Gupta, Asheeta, Milford, David, Muorah, Mordi, Bacchetta, Justine, Bernoux, Delphine, Bertholet-Thomas, Aurelia, Cheyssac, Elodie, Portefaix, Aurelie, Ranchin, Bruno, Sellier-Leclerc, Anne-Laure, Llanas, Brigitte, Baudouin, Veronique, Couderc, Anne, Hogan, Julien, Kaguelidou, Florentia, Kwon, Theresa, Maisin, Anne, Sas, David, Becker-Cohen, Rachel, Ben-Shalom, Efrat, Rinat, Choni, Behr, Shimrit Tzvi, Bockenhauer, Detlef, Mansour, Bshara, Pollack, Shirley, Garrelfs, Sander, Oosterveld, Michiel, Moochhala, Shabbir, Walsh, Stephen, Kamesh, Lavanya, Lipkin, Graham

Publikováno v: Clinical Journal of The American Society of Nephrology; July 2021, Vol. 16 Issue: 7 p1025-1036, 12p